Close Menu
New York Examiner News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Roseanne Barrs Ex-Husband Makes Shocking Sex Admission

    November 15, 2026

    Shane Gillis Says He Promised SNL His Monologue Would Have No Controversy

    November 14, 2026

    Fatherland, La Bola Negra, Fjord Lead European Film Award Nominations

    November 14, 2026
    Facebook X (Twitter) Instagram
    New York Examiner News
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    New York Examiner News
    Home»Science»Fauci Responds to Musk’s Twitter Attack and Rates World’s COVID Response
    Science

    Fauci Responds to Musk’s Twitter Attack and Rates World’s COVID Response

    By AdminDecember 17, 2022
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Fauci Responds to Musk’s Twitter Attack and Rates World’s COVID Response

    [ad_1]

    This month, Anthony Fauci will step down as director of the US National Institute of Allergy and Infectious Diseases (NIAID) after more than 38 years in the post and 54 years at its parent organization, the US National Institutes of Health (NIH). He has led the institute under seven US presidents and overseen its research and response to the HIV/AIDS epidemic, the Ebola outbreak that began in West Africa in 2014 and the COVID-19 pandemic. The 81-year-old physician-scientist became a household name during the pandemic, during which he was revered as a trusted source of advice by some and disparaged by others, including former US president Donald Trump, who saw his advice as inconsistent and overbearing. On 11 December, he was attacked on Twitter by Elon Musk, who took over the social-media platform in October. Fauci spoke to Nature about Musk’s comments, the pandemic and his own legacy.

    Thinking back on your decades at the NIH, in which area of infectious disease have we made the most progress?

    One of the most important is in the area of HIV. In 1981, when we first became aware of the cases of HIV, [it was] a mysterious disease of unknown etiology that was killing virtually everybody who was infected. It was one of the darkest periods of my or anybody’s professional career in infectious diseases. We went from that bleak time of not knowing what was killing all of these mostly young gay men to getting the [underlying virus], a diagnostic test and, within a few years, an entire series of drugs, which when used in combination, have completely transformed the lives of people with HIV. We also have developed highly effective prevention methods with pre-exposure prophylaxis and [can treat] people who are infected, bringing the level of virus to below detectable levels, so they don’t transmit it to anybody else.

    Where will we see the next revolution in infectious disease?

    One of the holy grails of infectious-disease research is a safe and effective vaccine for HIV. We’ve made spectacular advances in the development of therapies, both for treatment and prevention of disease. But the one thing that’s eluded us up to now has been a safe and effective vaccine. So that’s one of the things we look forward to. The other is the possibility, although it’s a stretch, in some respects, to have a cure for HIV, where you can have durable suppression or elimination and eradication of virus in the absence of any further therapy. We have not reached that point yet, but that is an aspirational goal.

    Your previous boss, former NIH director Francis Collins, lamented the lack of behavioural-science research to better understand misinformation about vaccines and other aspects of public health. Do we need to rethink how we incorporate social science into ‘hard’ biomedical science?

    Yes, we do. And you do it by just doing it. It’s not that difficult to incorporate a discipline of social sciences into the discipline of the hard sciences of developing vaccines. It is very disturbing that, in our country, we have 68% of the total population vaccinated with the primary vaccine for COVID. Of those, only half have received a single boost. And importantly, [despite] the availability of an effective BA.4/5 bivalent updated booster, only 13% of the eligible population has received it. That is very disturbing, and almost embarrassing for us that we have that low an enthusiasm about getting a life-saving vaccine.

    Beyond vaccine hesitancy, how can behavioural sciences play a part in pandemic responses?

    Another aspect that has been brought to the fore by COVID-19 is the importance of mental health, and paying attention to the stresses that [the pandemic] has put on society: not only on health-care workers, doctors and nurses, but also on the general population, including children. [Their] growth and development has been [shaped] not only by missing in-person school, but also by the stress of losing grandparents and parents, and seeing the disruption of the normal flow of their childhood. All of that has had a major negative impact on mental health.

    During the COVID-19 pandemic, we’ve seen governments censor scientists, distort data and otherwise act in bad faith, which makes international collaboration on preventing pandemics difficult. How can researchers toe this tricky line?

    That’s impossible to answer. If there are countries or groups that are not transparent, that’s a big hindrance to the global public-health effort. And I would hope that all the countries of the world come to a realization that we’ve got to be completely cooperative, collaborative and transparent in everything we do, because there’s no such thing as a pandemic, particularly of an infectious disease spread by the respiratory route, that’s going to stay in one country. We saw that very painfully with how COVID spread throughout the world and has already resulted in close to seven million deaths, and that’s probably a gross underestimate.

    How would you score the world’s response to the pandemic?

    It’s very difficult to give a fair [answer], because when you’re dealing with a virus as formidable as this, you are going to get deaths. But the global community, including the United States, certainly could have done better. The one success story has been the rapid development and deployment of vaccines. What has not been as successful is the public-health response. Take this country as an example. Over the decades, we have let our public-health system atrophy [by] not replacing people who leave, not keeping the equipment up to date, not getting [information] accessible in real time. We’ve had to go to other countries to get real-time information: the UK, Israel, South Africa. Whereas in our system of reporting, the states don’t have to report to the CDC [US Centers for Disease Control and Prevention]—the CDC has to ask them to participate in the response. That really has got to change.

    On Sunday, entrepreneur Elon Musk called for your prosecution, claiming that you lied to Congress and funded research that killed millions of people. How do you respond to the tweets?

    I don’t pay attention to that, Max, and I don’t feel I need to respond. I don’t tweet. I don’t have a Twitter account. A lot of that stuff is just a cesspool of misinformation, and I don’t waste a minute worrying about it.

    Do you feel that your safety is at risk, given Musk’s enormous reach on Twitter?

    Of course it’s at risk. That’s why I have armed federal agents with me all the time. That stirs up a lot of hate in people who have no idea why they’re hating—they’re hating because somebody like that is tweeting about it.

    On that note, what advice would you give to early-career scientists who might be rethinking their career choices after seeing some of the vitriol directed at you and other public-health officials during the pandemic?

    I would encourage them not to be deterred, because the satisfaction and the degree of contribution you can make to society by getting into public service and public health is immeasurable. It’s really extraordinary. It overcomes and counters all of the other bad stuff. It’s unfortunate that we are going through the attacks on public-health officials. But the satisfaction and the accomplishments you can [achieve] in the field are great. And it certainly supersedes all that other stuff.

    I understand you’re still formulating your plans after you leave the director post, is that right?

    Well, I’m going to write and lecture, and possibly [write] a memoir. But I’m certainly not going to retire in the classic sense.

    This article is reproduced with permission and was first published on December 13 2022.

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleThe Way of Water’ Opening on Lower End of Expectations – The Hollywood Reporter
    Next Article Tech’s latest controversy? The return of the five-day, in-person work week • TechCrunch

    RELATED POSTS

    Climate Change Has Pushed the World's Ice Out of Its Safe Zone

    November 12, 2026

    Synchron Pauses Trials of Its Brain Implant Due to Performance Issues

    November 12, 2026

    The Polar Vortex Is About to Make Weather Weird From the UK to the US

    November 12, 2026

    A Startup Wants to Fight AI Bioweapons With AI

    November 11, 2026

    Michigan Residents Voted to Get Corporate Money Out of Politics. Now Utilities Are Suing

    November 11, 2026

    Chatbots Are Leading Hikers Astray, With Dangerous Consequences

    November 1, 2026
    latest posts

    Roseanne Barrs Ex-Husband Makes Shocking Sex Admission

    Roseanne Barr recently revealed plans for a comeback eight years after she was “canceled.” The…

    Shane Gillis Says He Promised SNL His Monologue Would Have No Controversy

    November 14, 2026

    Fatherland, La Bola Negra, Fjord Lead European Film Award Nominations

    November 14, 2026

    Journey Drummer Deen Castronovo Exits Mid-Tour to Focus on His Health

    November 14, 2026

    3 Best Movies To Watch On HBO Max This Weekend ($1 Is Sydney Sweeneys $100 Million Sci-Fi Thriller)

    November 14, 2026

    Happys Place: Reba McEntire Teases Whats Next for Bobbie & JB

    November 14, 2026

    Amazons new Kindle Colorsoft is a premium e-reader with a premium price | TechCrunch

    November 14, 2026
    Categories
    • Books (1,588)
    • Business (6,481)
    • Events (85)
    • Film (6,447)
    • Lifestyle (4,500)
    • Music (6,580)
    • Politics (6,447)
    • Science (5,848)
    • Technology (6,435)
    • Television (6,140)
    • US News (6,484)
    popular posts

    New Mystery and Thriller Books to Read | March 17

    [ad_1] Hold on to the edge of your seat as we hunt for clues and…

    Trump Says Gas Prices Might Be Even Higher By The Midterm Election

    April 13, 2026

    the cursed, perverse realities of Adult Swim infomercials

    August 6, 2024

    Has Iran Won the War? It Thinks So By Howard Bloom

    May 22, 2026
    Archives
    Browse By Category
    • Books (1,588)
    • Business (6,481)
    • Events (85)
    • Film (6,447)
    • Lifestyle (4,500)
    • Music (6,580)
    • Politics (6,447)
    • Science (5,848)
    • Technology (6,435)
    • Television (6,140)
    • US News (6,484)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    Happys Place: Reba McEntire Teases Whats Next for Bobbie & JB

    November 14, 2026

    Amazons new Kindle Colorsoft is a premium e-reader with a premium price | TechCrunch

    November 14, 2026

    Rosalía makes history with Album Of The Year award win at Latin Grammys and performs Lux medley

    November 13, 2026
    © 2026 New York Examiner News. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT